HPGDS and neoplasm: In acute promyelocytic leukemia (APL), it has been shown that PGD2 produced by tumor cells activates type 2 innate lymphoid cells (ILC2), which, in turn, foster M-MDSCs towards immunosuppression and dampening of the anti-tumor immune response (198).